The high prevalence of obstructive sleep apnea (OSA) is closely tied to the country's obesity epidemic with vast implications to the United States healthcare system (1,2). Using cross-sectional analyses, the direct cost of untreated OSA has been estimated at over 3 billion dollars annually (3). This cost is magnified by indirect expenses (including lost income and work productivity), absenteeism, and accidents, making the appropriate management of OSA a noteworthy public health issue (4-6). There is a paucity of data in literature evaluating the economic impact of managing OSA in the United States (7), the majority of published reports being derived from other countries.
http://ift.tt/2xlMNKL
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου